Sudeshna Mukherjee
Overview
Explore the profile of Sudeshna Mukherjee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
747
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Inhibition of autophagy in platelets as a therapeutic strategy preventing hypoxia induced thrombosis
Bandyopadhyay P, Katakia Y, Mukherjee S, Majumder S, Chowdhury S, Chowdhury R
Sci Rep
. 2025 Feb;
15(1):6855.
PMID: 40011551
Hypoxia triggers activation of platelets, leading to thrombosis. If not addressed clinically, it can cause severe complications and fatal consequences. The current treatment regime for thrombosis is often palliative and...
2.
Choudhary A, Garge N, Ala C, Patel B, Patel V, Gurjar K, et al.
ACS Omega
. 2025 Feb;
10(6):5778-5794.
PMID: 39989793
Globally, breast cancer is the leading cause of mortality. Within the field of antibreast cancer drug design by several compound docking studies, eight new N-containing nonsteroid tetracyclic derivatives have been...
3.
Sharma A, Chowdhury S, Mukherjee S, Chowdhury R
Biol Cell
. 2024 Jul;
116(9):e2400034.
PMID: 38949568
Background Information: One of the confounding factors in pancreatic cancer (PC) pathogenesis is hyperglycemia. The molecular mechanism by which high glucose (HG) influences PC severity is poorly understood. Our investigation...
4.
Das N, Mukherjee S, Das A, Gupta P, Bandyopadhyay A, Chattopadhyay S
Heliyon
. 2024 Jan;
10(1):e23870.
PMID: 38226217
Epidemiological as well as experimental studies have established that the pineal hormone melatonin has inhibitory effects on different types of cancers. Several mechanisms have been proposed for the anticancer activities...
5.
Gautam D, Srivastava A, Chowdhury R, Laskar I, Rao V, Mukherjee S
J Acoust Soc Am
. 2023 Sep;
154(3):1787-1799.
PMID: 37725520
Viscosity is an essential parameter that regulates bio-molecular reaction rates of diffusion-driven cellular processes. Hence, abnormal viscosity levels are often associated with various diseases and malfunctions like cancer. For this...
6.
Srivastava A, Sharma H, Chowdhury S, Chowdhury R, Mukherjee S
Heliyon
. 2023 Apr;
9(4):e14665.
PMID: 37095942
Hepatocellular carcinoma (HCC) frequently unfolds under an inflammatory condition, which is a hub for a plethora of cytokines. A better understanding of the cytokine functions and their contributions to disease...
7.
Mani N, Daiya A, Chowdhury R, Mukherjee S, Chowdhury S
Adv Cancer Res
. 2023 Mar;
158:293-335.
PMID: 36990535
Traditional chemotherapy against cancer is often severely hampered by acquired resistance to the drug. Epigenetic alterations and other mechanisms like drug efflux, drug metabolism, and engagement of survival pathways are...
8.
Saini H, Dave R, Chatterjee S, Mandloi A, Sharma H, Daiya A, et al.
Gene
. 2023 Feb;
864:147304.
PMID: 36822527
Over the years, the landscape of cisplatin-based cancer treatment options has undergone continuous transitions. Currently, there is much debate over the optimum dose of cisplatin to be administered to cancer...
9.
Mukherjee S, Gupta P, Ghosh S, Choudhury S, Das A, Ahir M, et al.
J Nutr Biochem
. 2023 Feb;
115:109283.
PMID: 36791995
One of the key biochemical features that distinguish a cancer cell from normal cells is its persistent pro-oxidative state that leads to intrinsic oxidative stress. Malignant cells have evolved sophisticated...
10.
Dey S, Fageria L, Sharma A, Mukherjee S, Pande S, Chowdhury R, et al.
Toxicol Rep
. 2022 Dec;
9:1977-1984.
PMID: 36518460
Breast cancer is one of the most frequent forms of cancer. Although different treatment modalities are available, none has proved to be a game-changer. In this context, nanomedicine is one...